Novel Inhibitors Of Mycobacterium Tuberculosis Complex Cytochrome P450 Cyp121


The full document isn't yet available to us from the patent office.


The present invention relates to the identification of the cyclodipeptide cyclo(L-Tyr-L-Tyr) as substrate of CYP121 from Mycobacterium tuberculosis, to the crystal structures of CYP121 complexed either with cyclo(L-Tyr-L-Tyr) or with other cyclodipeptides, to the use of these structures in rational drug design methods to generate cyclodipeptide-based molecules that could inhibit CYP121 activity, and to the design of new anti- Mycobacterium tuberculosis agents based on the DKP scaffold.


Information currently unavailable.

Sign in to the Lens